Lynn Chen

Lynn Chen is an experienced scientist with a diverse background in bioscience and biotechnology. Lynn's career began with a research fellowship at the FDA, where significant work included developing assays for nanomaterials and evaluating their cytotoxicity. Subsequently, Lynn has held various roles in academia and the pharmaceutical industry, including teaching assistant positions at UMCP and The George Washington University, as well as scientist roles at Pfizer and AstraZeneca, focusing on protein purification and antibody generation. Lynn's expertise extends to high throughput production platforms and drug characterization methods, currently applied at IntegerBio since May 2024.